1 terminated. 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Terminated 1 |
| Phase 3 | 1 | Terminated 1 |
Follow Tularik: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| T138067 Versus Doxorubicin in Chemotherapy-Naive, Unresectable, Hepatocellular Carcinoma Patients T138067 intravenous, doxorubicin intravenous - Hepatocellular Carcinoma | Phase 2 / Phase 3 | Terminated | Tularik | 750 | 2003-03-01 | 2005-06-24 |
Carcinoma, Hepatocellular (1) · Liver Neoplasms (1)
Brazil (1) · China (1) · Poland (1) · Puerto Rico (1) · Russia (1) · Singapore (1) · South Africa (1) · Thailand (1) · Ukraine (1) · United Kingdom (1) · United States (1)